Literature DB >> 21694445

Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.

Kristina Biskupska Bodova1, Kamil Biringer, Karol Dokus, Jela Ivankova, Jan Stasko, Jan Danko.   

Abstract

OBJECTIVE: The purpose of this study was to examine plasma levels of fibronectin and plasminogen inhibitor type 1 (PAI-1), and alterations in uterine artery (UtA) waveforms throughout normotensive and preeclamptic pregnancies and to analyze its predictive value for the detection of preeclampsia within the second trimester of pregnancy.
MATERIAL AND METHODS: Blood samples were collected from 102 healthy, nulliparous women between the 24th and 26th gestational week. Preeclampsia developed in 13 patients; 89 normotensive control subjects were matched from the same cohort. Plasma samples were assayed for fibronectin and PAI-1 by enzyme-linked immunosorbent assay. Color pulsed Doppler examinations of UtA were performed after blood sampling. Trends were compared between two groups.
RESULTS: Maternal plasma fibronectin and PAI-1 levels and average PI, RI and S/D ratios of patients with preeclampsia were significantly higher (p< 0.05). The best cut-off values for predicting preeclampsia of fibronectin, PAI-1, PI, RI, S/D ratio based on ROC curve analysis were 290 mg/ml, 77.3 ng/ml, 1,0615, 0.605 and 2,59 respectively. The areas under the curve equal to 0.705, 0.753, 0.689, 0.695 and 0.699 for fibronectin, PAI-1 and uterine artery Doppler PI, RI, S/D ratio were determined for the prediction of preeclampsia.
CONCLUSIONS: Fibronectin, PAI-1 and UtA Doppler are potentially useful predictors of preeclampsia. Maternal plasma PAI-1 combinated with fibronectin had the highest predictive values in our study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21694445      PMCID: PMC3825071          DOI: 10.3233/DMA-2011-0772

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  9 in total

1.  Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study.

Authors:  Carmen A H Severens-Rijvers; Salwan Al-Nasiry; Chahinda Ghossein-Doha; Sara Marzano; Hugo Ten Cate; Bjorn Winkens; Marc A E Spaanderman; Louis L H Peeters
Journal:  Gynecol Obstet Invest       Date:  2016-09-20       Impact factor: 2.031

Review 2.  Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  World J Nephrol       Date:  2014-11-06

3.  Comparative proteome profile of human placenta from normal and preeclamptic pregnancies.

Authors:  Fuqiang Wang; Zhonghua Shi; Ping Wang; Wei You; Gaolin Liang
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

4.  High levels of HtrA4 observed in preeclamptic circulation drastically alter endothelial gene expression and induce inflammation in human umbilical vein endothelial cells.

Authors:  Yao Wang; Guiying Nie
Journal:  Placenta       Date:  2016-09-10       Impact factor: 3.481

5.  Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.

Authors:  S O Ajibola; T A Adeyemo; B B Afolabi; A S Akanmu
Journal:  Niger Med J       Date:  2016 Jul-Aug

Review 6.  Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases.

Authors:  Yao Ye; Aurelia Vattai; Xi Zhang; Junyan Zhu; Christian J Thaler; Sven Mahner; Udo Jeschke; Viktoria von Schönfeldt
Journal:  Int J Mol Sci       Date:  2017-07-29       Impact factor: 5.923

7.  Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study.

Authors:  Xiaoyan Chen; Zhaoming Liu; Jingen Cui; Xiaolan Chen; Jing Xiong; Wei Zhou
Journal:  Front Genet       Date:  2022-08-22       Impact factor: 4.772

8.  Fibrinolytic Changes in Women with Preeclampsia.

Authors:  Anne Cathrine Godtfredsen; Johannes Jakobsen Sidelmann; Britta Blume Dolleris; Jan Stener Jørgensen; Emma Kathrine Jungjohan Johansen; Melissa Fernard Bøg Pedersen; Yaseelan Palarasah; Jørgen Brodersen Gram
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

9.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.